MoneyWorks4Me

Biocon informs about company statement

29 Jul 2026 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Receives Health Canada Approval for Yesintek® (ustekinumab) Autoinjector Pen’. The above information will also be available on the website of the Company at www.biocon.com. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1138.70
Cipla 1372.40
Lupin 2083.50
Zydus Lifesciences 1116.45
View more..